RaySearch Laboratories ABSTU:27R +3.44%86 Median PS Value is €17.29 as of Jul. 03, 2026, which is 100% below its 10-year median of 0.63. GuruFocus rates STU:27R with a GF Score™ of 86/100 and a GF Value™ of €17.21. The stock has 2 warning signs investors should review. Among 263 Healthcare Providers & Services companies, RaySearch Laboratories AB ranks worse than 80.61% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for RaySearch Laboratories AB's Median PS Value or its related term are showing as below:
STU:27R'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.35 Med: 0.63 Max: 1.75
Current: 1.22
During the past 13 years, the highest Price to Median PS Value of RaySearch Laboratories AB was 1.75. The lowest was 0.35. And the median was 0.63.
STU:27R's Price-to-Median-PS-Value is ranked worse than 80.61% of 263
companies
in the Healthcare Providers & Services industry
Industry Median: 0.7
vs STU:27R: 1.22
RaySearch Laboratories AB (STU:27R) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
RaySearch Laboratories AB's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
21.02
/
17.29
=
1.22
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RaySearch Laboratories AB Median PS Value Related Terms
RaySearch Laboratories AB Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:27R vs VEEV, BTSG, TEM: Median PS Value Comparison
For the Health Information Services subindustry, RaySearch Laboratories AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RaySearch Laboratories AB Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where RaySearch Laboratories AB's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 4.9641.
RaySearch Laboratories AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.483.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RaySearch Laboratories AB (STU:27R) has a Median PS Value of €17.29 as of Jul. 03, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on RaySearch Laboratories AB and its competitors. This is 2644% above median its historical median of 0.63. Over the past decade, RaySearch Laboratories AB's Median PS Value has ranged from 0.35 to 1.75. According to the industry distribution chart, RaySearch Laboratories AB ranks #212 out of 263 companies in the Healthcare Providers & Services industry, placing it in the top 80.6%.
Is RaySearch Laboratories AB's Median PS Value too high?
RaySearch Laboratories AB's current Median PS Value of €17.29 is 2644% above median its 10-year median of 0.63. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 1.75. Based on the distribution chart, RaySearch Laboratories AB ranks #212 out of 263 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, RaySearch Laboratories AB has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Median PS Value compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, RaySearch Laboratories AB ranks #212 out of 263 companies for Median PS Value. This places RaySearch Laboratories AB in the lower half of its industry. The industry median Median PS Value is 0.70. Historically, RaySearch Laboratories AB's own Median PS Value has ranged from 0.35 to 1.75 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.70, based on 263 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on RaySearch Laboratories AB and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RaySearch Laboratories AB's current Median PS Value is €17.29, which is 2644% above median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
RaySearch Laboratories AB (STU:27R) has a current Median PS Value of €17.29. The stock's GF Value™ is €17.21, compared to a current price of €21.02 — trading 22.1% above its estimated fair value. The current Median PS Value is €17.29, which is 2644% above median its 10-year median of 0.63. RaySearch Laboratories AB's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For RaySearch Laboratories AB (STU:27R), the current Median PS Value is €17.29 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RaySearch Laboratories AB (STU:27R) Overvalued in 2026?
Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued.
The current stock price of €21.02 is trading 22.1% above its estimated GF Value™ of €17.21.
Key valuation signals for STU:27R:
Median PS Value: €17.29 (2644% above median its 10-year median of 0.63)
GF Value™: €17.21 vs. price of €21.02 (22.1% above fair value)
No single metric tells the full story. See the STU:27R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
86GF Score
Get the complete analysis for STU:27R
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:27R has been successfully added to your 
